A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase III studies in the patients with EGFR-mutant demonstrated that EGFR-TKI mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hisashi, Hayashi, Akihito, Morimoto, Takeshi, Taima, Kageaki, Tanaka, Yoshihito, Shimada, Michiko, Kurose, Akira, Takanashi, Shingo, Okumura, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515412/
https://www.ncbi.nlm.nih.gov/pubmed/23181703
http://dx.doi.org/10.1186/1471-2407-12-558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515412/
https://www.ncbi.nlm.nih.gov/pubmed/23181703
http://dx.doi.org/10.1186/1471-2407-12-558

Ejemplares similares